Regulation of p53 by the 14-3-3 protein interaction network: new opportunities for drug discovery in cancer
Open Access
- 16 November 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell Death Discovery
- Vol. 6 (1), 1-21
- https://doi.org/10.1038/s41420-020-00362-3
Abstract
Most cancers evolve to disable the p53 pathway, a key tumour suppressor mechanism that prevents transformation and malignant cell growth. However, only ~50% exhibit inactivating mutations of p53, while in the rest its activity is suppressed by changes in the proteins that modulate the pathway. Therefore, restoring p53 activity in cells in which it is still wild type is a highly attractive therapeutic strategy that could be effective in many different cancer types. To this end, drugs can be used to stabilise p53 levels by modulating its regulatory pathways. However, despite the emergence of promising strategies, drug development has stalled in clinical trials. The need for alternative approaches has shifted the spotlight to the 14-3-3 family of proteins, which strongly influence p53 stability and transcriptional activity through direct and indirect interactions. Here, we present the first detailed review of how 14-3-3 proteins regulate p53, with special emphasis on the mechanisms involved in their binding to different members of the pathway. This information will be important to design new compounds that can reactivate p53 in cancer cells by influencing protein–protein interactions. The intricate relationship between the 14-3-3 isoforms and the p53 pathway suggests that many potential drug targets for p53 reactivation could be identified and exploited to design novel antineoplastic therapies with a wide range of applications.Keywords
This publication has 136 references indexed in Scilit:
- MdmX Protein Is Essential for Mdm2 Protein-mediated p53 PolyubiquitinationOnline Journal of Public Health Informatics, 2011
- COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σOncogene, 2011
- Bioinformatic and experimental survey of 14-3-3-binding sitesBiochemical Journal, 2010
- ATM activates p53 by regulating MDM2 oligomerization and E3 processivityThe EMBO Journal, 2009
- 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramersNucleic Acids Research, 2008
- Elevated Levels of Oncogenic Protein Kinase Pim-1 Induce the p53 Pathway in Cultured Cells and Correlate with Increased Mdm2 in Mantle Cell LymphomaOnline Journal of Public Health Informatics, 2008
- Phosphorylation of MDMX Mediated by Akt Leads to Stabilization and Induces 14-3-3 BindingOnline Journal of Public Health Informatics, 2008
- Acetylation of the p53 DNA-Binding Domain Regulates Apoptosis InductionMolecular Cell, 2006
- Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fateThe Journal of cell biology, 2006
- 14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphataseThe EMBO Journal, 2003